Rhumbline Advisers »

Innate Pharma shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $574 205 2.80
2023-09-30 $517 205 2.53
2023-06-30 $643 205 3.14